| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.024 | 0.6 |